Acadia Pharmaceuticals buy Mizuho
Start price
23.02.26
/
50%
€20.85
Target price
23.02.27
€29.59
Performance (%)
-13.26%
Price
14:27
€18.12
Summary
This prediction is currently active. The price of Acadia Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -13.26%. This prediction currently runs until 23.02.27. The prediction end date can be changed by Mizuho at any time. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | -0.911% | -0.911% |
| iShares Core DAX® | -3.640% | -8.784% |
| iShares Nasdaq 100 | -2.986% | -1.710% |
| iShares Nikkei 225® | -3.000% | -9.097% |
| iShares S&P 500 | -2.389% | -2.781% |
Comments by Mizuho for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals (NASDAQ:ACAD) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $35.00 price target on the stock, up previously from $29.00.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Mizuho for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.60
28.02.24
28.02.24
€36.02
28.02.25
28.02.25
-19.75%
01.03.25
01.03.25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€28.40
29.12.23
29.12.23
€36.19
29.12.24
29.12.24
-42.54%
30.12.24
30.12.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€22.40
06.11.23
06.11.23
€32.59
06.11.24
06.11.24
-31.70%
07.11.24
07.11.24